Faecal calprotectin: Management in inflammatory bowel disease

Table 1 Monitoring of inflammatory bowel disease with biomarkers

Advantages	Disadvantages
Relatively good acceptance	Not always well accepted by patients (faecal samples)
Non-invasive	Subject to non-specific variations
Relatively low cost	Predictive threshold values not fully established
May be combined to improve prediction	Imperfect correlation with mucosal healing and transmural healing
Can be repeated as a longitudinal monitoring tool
Predictive value for
Disease relapse
Response to anti-TNF therapy
Mucosal healing

TNF: Tumor necrosis factor.